PB2051: POPULATION PHARMACOKINETIC/PHARMACODYNAMIC/EFFICACY MODELING OF SB12 (PROPOSED ECULIZUMAB BIOSIMILAR) AND REFERENCE ECULIZUMAB
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-08-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/01.HS9.0000975004.91980.ef |
| _version_ | 1827331946640834560 |
|---|---|
| author | Hyuna Lee Jihye Park Hyerin Jang Jungryul Kim |
| author_facet | Hyuna Lee Jihye Park Hyerin Jang Jungryul Kim |
| author_sort | Hyuna Lee |
| collection | DOAJ |
| first_indexed | 2024-03-07T16:47:45Z |
| format | Article |
| id | doaj.art-f53d33c9162d468a87d2604b7c28c758 |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T16:47:45Z |
| publishDate | 2023-08-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-f53d33c9162d468a87d2604b7c28c7582024-03-03T06:24:35ZengWileyHemaSphere2572-92412023-08-017e91980ef10.1097/01.HS9.0000975004.91980.ef202308003-01925PB2051: POPULATION PHARMACOKINETIC/PHARMACODYNAMIC/EFFICACY MODELING OF SB12 (PROPOSED ECULIZUMAB BIOSIMILAR) AND REFERENCE ECULIZUMABHyuna Lee0Jihye Park1Hyerin Jang2Jungryul Kim31 Samsung Bioepis, Clinical development, Korea, Rep. of South1 Samsung Bioepis, Clinical development, Korea, Rep. of South1 Samsung Bioepis, Clinical development, Korea, Rep. of South2 Samsung Medical Center, Department of Clinical Pharmacology and Therapeutics, Seoul, Korea, Rep. of Southhttp://journals.lww.com/10.1097/01.HS9.0000975004.91980.ef |
| spellingShingle | Hyuna Lee Jihye Park Hyerin Jang Jungryul Kim PB2051: POPULATION PHARMACOKINETIC/PHARMACODYNAMIC/EFFICACY MODELING OF SB12 (PROPOSED ECULIZUMAB BIOSIMILAR) AND REFERENCE ECULIZUMAB HemaSphere |
| title | PB2051: POPULATION PHARMACOKINETIC/PHARMACODYNAMIC/EFFICACY MODELING OF SB12 (PROPOSED ECULIZUMAB BIOSIMILAR) AND REFERENCE ECULIZUMAB |
| title_full | PB2051: POPULATION PHARMACOKINETIC/PHARMACODYNAMIC/EFFICACY MODELING OF SB12 (PROPOSED ECULIZUMAB BIOSIMILAR) AND REFERENCE ECULIZUMAB |
| title_fullStr | PB2051: POPULATION PHARMACOKINETIC/PHARMACODYNAMIC/EFFICACY MODELING OF SB12 (PROPOSED ECULIZUMAB BIOSIMILAR) AND REFERENCE ECULIZUMAB |
| title_full_unstemmed | PB2051: POPULATION PHARMACOKINETIC/PHARMACODYNAMIC/EFFICACY MODELING OF SB12 (PROPOSED ECULIZUMAB BIOSIMILAR) AND REFERENCE ECULIZUMAB |
| title_short | PB2051: POPULATION PHARMACOKINETIC/PHARMACODYNAMIC/EFFICACY MODELING OF SB12 (PROPOSED ECULIZUMAB BIOSIMILAR) AND REFERENCE ECULIZUMAB |
| title_sort | pb2051 population pharmacokinetic pharmacodynamic efficacy modeling of sb12 proposed eculizumab biosimilar and reference eculizumab |
| url | http://journals.lww.com/10.1097/01.HS9.0000975004.91980.ef |
| work_keys_str_mv | AT hyunalee pb2051populationpharmacokineticpharmacodynamicefficacymodelingofsb12proposedeculizumabbiosimilarandreferenceeculizumab AT jihyepark pb2051populationpharmacokineticpharmacodynamicefficacymodelingofsb12proposedeculizumabbiosimilarandreferenceeculizumab AT hyerinjang pb2051populationpharmacokineticpharmacodynamicefficacymodelingofsb12proposedeculizumabbiosimilarandreferenceeculizumab AT jungryulkim pb2051populationpharmacokineticpharmacodynamicefficacymodelingofsb12proposedeculizumabbiosimilarandreferenceeculizumab |